This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
CBN has made headlines and claimed shelf space as the next best cannabinoid for sleep. MoreBetter, creators of the Releaf App, is using this real world data to push back against the claim that there’s no evidence that CBN can help people sleep. It also, allegedly, helps with sleep (more on that below). Back to our study.
We know sleep is important. And while research suggests that we’re meant to get at least 7-8 hours a day to function at our best, many around the globe still aren’t getting enough sleep. Participants also found it easier and easier to fall asleep while using the Deep Zzzs sleep gummy. hours to 6.79
Adults who purchase retail cannabis typically report using it to mitigate pain and to improve sleep, and often use it in place of conventional medications, according to data published online today in the Journal of Psychoactive Drugs.
So it’s not surprising that products that combine cannabis and melatonin are making their way into legal marketing – and according to real world data gathered in a recent campaign on The Cannigma, it’s a winning combination. What’s in FOCL’s DEEP SLEEP, Full Spectrum+ Gummies? The average level of sleep disturbance was 58.67
My partner, who was diagnosed with Crohn’s Disease at the age of 19, was able to improve his quality of life with cannabis by managing his nausea, poor quality sleep, gut motility, appetite, pain, and anxiety with a single substance. I also advocated alongside my partner for many years as part of the patient group United Patients Alliance.
The Cannigma has always taken a data-informed approach to content creation – though up until recently we’ve been primarily leaning on the existing peer-reviewed literature to guide our content. We need more data – human data – on specific applications for the plant – symptoms, use cases, conditions and patient types.
According to a recent study published in the Journal of Headache Pain , across 2,032 patients and 21 illnesses, headache was a symptom treated with cannabis in 24.9% (505) of cases, while 88% (445) of headache patients treated probable migraines with cannabis. 30 percent of migraine patients in the U.S. The results?
New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).
Published in Nature , the study found that just under a third of patients report significant improvements and over half report moderate improvements while using CBD -rich oil derived from cannabis (30% CBD , 1-2% THC ). Cannabis and ADHD.
Sleep is an essential activity that assists with the alignment of the body’s circadian rhythm – A.K.A. ” A variety of things may impact a person’s sleep, but what about the people who struggle with irregular sleep patterns daily? However, the psychotropic compound could cause long-term sleep impairment.
Pain, anxiety, and sleep are major drivers of medical cannabis use. In a newly published survey of 162 IBD patients in Puerto Rico, where medical cannabis is legal but recreational use is punishable with prison time , about 25% anonymously reported using cannabis to treat their symptoms. Among these, nearly all said it offered relief.
Cancer patients arguably stand to benefit the most from cannabis’ unique properties and benefits, such as anti-nausea, anti-inflammation, reduced pain, inhibited tumor growth, and appetite stimulation. Even still, the “odds of a cancer patient using marijuana in the past year were essentially flat between 2013 and 2018.”
Instead, patients turn to a mix of whatever individual medications, therapies, and lifestyle changes (especially exercise) help ease symptoms and improve quality of life. “Available data strongly support the use of cannabinoids in treating fibromyalgia pain” due to “overwhelmingly positive treatment results.”
Of the 1,276 participants, 524 adult patients and 284 adult caregivers of children or dependent adults, all self-reported using cannabis for medicinal purposes. The control group consisted of 271 adult patients who were considering cannabis use, and 197 adult caregivers who were considering it for a dependent child or adult patient.
On top of recognizing the vast scope of benefits cannabis can provide, patients are saving lots of hard-earned money by swapping their pills for cannabis. The team that conducted the study looked at stock return and prescription drug sales data for 556 pharmaceutical companies. Why Patients Are Choosing MMJ Over Pharmaceuticals.
CBD could “significantly reduce opioid use and improve chronic pain and sleep quality among patients who are currently using opioids for pain management”, according to a new study. The primary inclusion criteria included patients between 30 and 65 years old with chronic pain who have been on opioids for at least 1 year.
Dr. Goldstein has treated thousands of patients with medical cannabis. And it does appear to address some of the main issues that people turn to cannabis for — inflammation, pain, anxiety, sleep problems, depression, and cancer. It was highly rated for anxiety, pain, depression, and sleep problems.
For the next couple days, she got extra sleep to aid recovery, and for good measure took an extra dose or two of CBD. Whatever the precise nature of the phantom sound, it often comes with a constellation of symptoms related to the disruption such a condition can bring: sleep problems, difficulty concentrating, low mood, etc.
Patients who suffer from epilepsy , which affects some 3.4 million people across the United States , report experiencing improved quality of life and a more restful night’s sleep after consuming the non-psychoactive cannabinoid CBD (cannabidiol). Researchers Analyzed Survey Results from 280 Epilepsy Patients.
This efficacy translates to better medicine and better treatments for patients. Myrcene has potent anti-inflammatory, analgesic, and anxiolytic properties, and has benefit in muscle relaxation, and prominent sedation/hypnotic, helpful in sleep. This means that as a team these compounds make cannabis stronger and more efficient.
Cannabinoids can promote sleep by activating receptors in the brain called endocannabinoid receptors CB1R and CB2R that regulate sleep cycles, pain perception, immune responses and moods such as depression. They can also promote sleep by activating receptors in the brain that regulate circadian rhythm (the biological clock).
But newer research, including from this year, has indicated that cannabinoid suppositories do have clinical utility, and real-world data collected recently from Cannigma users shows that a CBD product based on a full extract cannabis oil (FECO) can significantly improve menstrual symptoms. And she got what she was looking for!
Are you able to answer your patients’ medical marijuana questions? and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ million medical marijuana patients nationwide. Written by Dr. Meredith Fisher-Corn, MD , Editor-in-Chief at TheAnswerPage.com.
Fast-forward to 2020, and Smith and two co-founders launched “Tetragram,” a mobile app designed to help medical cannabis patients determine which products — including which strains, formulations, and delivery methods — work best for their ailments or even their recreational use goals. Do you just want to get a good night’s sleep?
Technology-enabled clinical research company People Science is carrying out a study into the effects of cannabinoids on sleep behavior. Study subjects were invited to participate in People Science’s cannabis sleep study from home. The findings were featured in the Journal of Sleep Research. People Science Raises $5.3M
The Data and Safety Monitoring Committee (“DSMC”) for IGC’s clinical trial, having reviewed the data obtained through Cohort 1 and Cohort 2, recommended progressing to Cohort 3, which consists of administering three doses per day. As the disease progresses, individuals may suffer from loss of memory and dementia.
They argued that their findings suggest that doctors “outside of the VHA system who treat veteran patients may need to take the lead in conversations surrounding medical marijuana as a treatment option.”. Veterans collectively discussed how the use of medical marijuana reduced PTSD symptoms, feelings of anxiety, and helped them sleep better.
In the novel study conducted by researchers at the University of New Mexico, nearly 2,000 people self-administered cannabis over a three-year period and reported their marijuana use via the Releaf App that was specifically designed for the study’s data collection needs.
According to a New Frontier Data Report, the overall legal cannabis industry in America is valued at roughly $13.2 We will be expanding production in sync with how the patient population grows, and we will continue to offer the broadest product selection for our patients and continue to innovate as well,” said Ruark.
Chronic pain patients who used cannabis saw sustained improvement in their condition over time, according to the results of a recently released study. The data revealed a sustained improvement in the participants’ symptoms. The data revealed a sustained improvement in the participants’ symptoms. View original article.
annually — is one of the most common reasons why medical marijuana is sought out by patients in the United States, Canada, and beyond. The list is designed to help patients determine whether or not they are a good candidate for (and would benefit from) a medical marijuana card. Chronic pain —a condition that affects 50.2
The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.
A Windsor, Ontario-based company Audacia Bioscience is especially focussed on three patented technologies that deliver consumer and patient insights to the industry to close the knowledge gaps in the supply chain. Cognizance VCT enables the generation of cost-effective quality data with ethical consent, on par with academic studies.
Report: Gen Z Would Rather Smoke Cannabis Than Consume Alcohol To collect this data, Veriheal surveyed thousands of patients between the ages of 15 and 27 who signed up for our services between March 2023 and April 2024. It can also help with sleep, as many people like to use cannabis right before bed to feel immediate effects.
People who suffer from fatigue may struggle with physical exertion, weight fluctuation, depression, emotional imbalance, and sleeping disturbances. Data was pulled from 3,922 cannabis self-administration sessions with the help of this application. Promising News for Endless Patients.
Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). Patient-reported outcomes. PROGRAMME.and.ABSTRACTS. Improved quality of life.
Quemarr’s transformative approach to diabetes treatment offers patients a less intrusive alternative to conventional insulin treatments. The buddie can be paired with a mobile app that tracks consumption, correlating it with health data from devices like WHOOP, Apple Watch, or Fitbit.
Still, the data also suggests that using cannabidiol (CBD) can reverse or prevent these issues — and that both CBD and THC may have big potential benefits for those suffering from Alzheimer’s disease. To do this, it regulates a number of bodily functions such as sleep, hunger, energy, temperature, pain, and immune function.
Almost 25% of patients with Parkinson’s disease reported that they had used cannabis in the prior six months in a survey from the Parkinson’s Foundation. Less well-known symptoms include sleep disorders , cognitive changes, pain, anxiety, depression , and hallucinations. More Than 1,000 PD Patients Surveyed.
For the study researchers “included data from people in 2 prospective cohorts. The most commonly reported therapeutic reasons for cannabis use were pain (36%), sleep (35%), stress (31%), and nausea (30%).” However, there is a lack of research using individual-level data to explore this question. Methods and findings.
The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.
This article explores the profound impact of MMJ on Maryland communities, shedding light on the medical marijuana benefits experienced by patients and the positive effects it has had on the state’s communities. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions.
Because of the very rapid progression of ALS in the majority of patients, understanding how cannabis could help in the alleviation of symptoms is incredibly important for ALS sufferers. Both upper and lower motor neurons suffer severe damage in ALS patients. As few as 10% of ALS patients live longer than 10 years after being diagnosed.
A Cornell University research program, reviewing Medicaid patientdata over the past decade in 10 states and Washington DC where recreational marijuana has been legalized, has found that drug prescriptions for anxiety, sleep, pain and seizures have fallen as a result of cannabis legalization, going beyond the findings of similar studies about the impact (..)
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content